Representative before the EPO

Employment test 11 - 50 employees
Company dna zsp patentanwalte
operating since 1992
Headquarter in Munich and 1 office
active in Legal Services and IP Consulting

Representative before the EPO

Company dna dr volker vossius patent und rechtsanwaltskanzlei
no operation time available
1 office
active in Legal Services

We have observed 4 EP applications Thomas Wilk has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 27, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP15197357

METHODS AND KITS TO DETECT HEREDITARY ANGIOEDEMA TYPE III

IPC classification:
A01K 67/027, A61K 48/00, C12Q 1/68, G01N 33/53
Agent:
Thomas Wilk, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Anton Hutter, Venner Shipley LLP
Status:
APPLICATION PUBLISHED
EP16176546

GENETIC PRODUCTS WHICH ARE DIFFERENTIALLY EXPRESSED IN TUMOURS AND USE THEREOF

IPC classification:
C07K 14/47, C07K 16/30, C12Q 1/68
Applicant:
BioNTech AG
Agent:
Thomas Wilk, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
APPLICATION PUBLISHED
EP16202946

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER

IPC classification:
A61K 39/395
Applicant:
Johannes Gutenberg University Mainz (Johannes Gutenberg-Universität Mainz)
Applicant:
Ganymed Pharmaceuticals AG
Agent:
Thomas Wilk, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
APPLICATION PUBLISHED
EP17171169

COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

IPC classification:
A61K 39/395, A61K 45/06, C07K 16/30
Applicant:
Ganymed Pharmaceuticals AG
Applicant:
TRON Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gGmbH
Agent:
Thomas Wilk, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
The application has been published

Please Sign in to use this feature